BCI & Neuroscience

Brain-computer interfaces in early 2026 are at an inflection point. Neuralink's PRIME study has implanted approximately 20 patients who can control computers through thought, with international expansion to the UK and UAE underway. Synchron's Stentrode has met its primary endpoint in a 12-month feasibility trial with 6 patients — the first FDA-approved permanently implanted BCI to achieve this — and secured $200M for pivotal trials.

Speech BCI has emerged as a new high-impact frontier. The BIT framework achieves 10% word error rate for brain-to-text decoding (down from 24.69% SOTA), using contrastive learning to align neural signals with audio LLM representations. Stanford has demonstrated decoding of private inner speech from motor cortex, finding that inner speech patterns are attenuated versions of attempted speech — meaning existing BCIs can potentially be adapted for thought-to-text communication.

Frontier — What's Moving Now

• Synchron primary endpoint met — 12-month data, 6 patients, $200M Series D for pivotal trials.
• Speech BCI: 10% WER — BIT framework bridges neural signals to text via audio LLMs.
• Inner speech decoded — Stanford shows thought patterns decodable from motor cortex.
• Invasive BCI scaling — Neuralink ~20 patients, UK/UAE expansion.
• Non-invasive improving — Deep learning + flexible bioelectronics compounding gains.

Concept Map

Concepts

Entities

Timeline

See timeline.md for chronological developments (2004 through 2026).

Research Frontier

See frontier.md for active research directions, breakthroughs, and knowledge gaps.

Sources